Jazz pharmaceuticals plc (nasdaq: jazz), a global biopharmaceutical company, is dedicated to developing life-changing medicines for people with limited or no options, so they can live their lives more fully and redefine what is possible. as a leader in sleep medicine and with a growing presence in hematology/oncology, we have a diverse portfolio of products and product candidates in development and are focused on transforming biopharmaceutical discoveries into novel medicines. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has a significant corporate presence in palo alto, ca, philadelphia, pa and oxford, england, with manufacturing facilities in ireland and italy. we maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. together, we are more than 1,500 experts, analysts, specialists, advocates, scientists and professionals – across 13 offices and nearly 20 countries – all with diverse backgrounds and perspectives, but all working together to support patients, innovate and bring new medicines to market. for more information, please see our website at www.jazzpharma.com and follow us on twitter at @jazzpharma. for information on fraudulent schemes involving our company name and recruitment, please visit https://bit.ly/2j1ejma. for guidelines on engaging with jazz on social media, please visit https://bit.ly/2oamouq.